Skip to main content
. 2015 Mar 13;35(5):1230–1236. doi: 10.3892/ijmm.2015.2138

Figure 5.

Figure 5

Restriction fragment length analysis showed that the p.S341P mutation abolished a CviKI-1 site co-segregated with POAG patients (096002, 096003 and 096005), ocular hypertension (096006), and carriers (096008 and 096009), but not with unaffected individuals (096001, 096004, 096007, 096010, 096011 and 096012).